SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-19-014287
Filing Date
2019-03-12
Accepted
2019-03-12 20:59:37
Documents
6
Effectiveness Date
2019-03-12

Document Format Files

Seq Description Document Type Size
1 S-8 a19-6135_1s8.htm S-8 107277
2 EX-5.1 a19-6135_1ex5d1.htm EX-5.1 22599
3 EX-23.2 a19-6135_1ex23d2.htm EX-23.2 3334
4 EX-23.3 a19-6135_1ex23d3.htm EX-23.3 2995
5 EX-99.1 a19-6135_1ex99d1.htm EX-99.1 79662
6 GRAPHIC g61351kii001.jpg GRAPHIC 2064
  Complete submission text file 0001104659-19-014287.txt   219950
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230216 | Film No.: 19676670
SIC: 2834 Pharmaceutical Preparations